Fenfluramine: a plethora of mechanisms?
Developmental and epileptic encephalopathies are rare, treatment-resistant epilepsies with high seizure burden and non-seizure comorbidities. The antiseizure medication (ASM) fenfluramine is an effective treatment for reducing seizure frequency, ameliorating comorbidities, and potentially reducing r...
Saved in:
Main Authors: | Jo Sourbron (Author), Lieven Lagae (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012) -
Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
by: Gianluca Dini, et al.
Published: (2022) -
A review of fenfluramine for the treatment of Dravet syndrome patients
by: Kayla Simon, et al.
Published: (2022) -
Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
by: Gianluca Dini, et al.
Published: (2023) -
In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
by: Parthena Martin, et al.
Published: (2022)